Cashu Finance
  • Terminal
  • Stocks
  • Spotlight
  • Research
Log inSign Up
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. IMNN

Market Cap: $6.18M

II

Imunon, Inc.

IMNN
NASDAQ (NASDAQ Capital Market)USD
Purchase IMNN
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutivePatentsEarnings Surprise
Cashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Recent Patents

imnn
over 1 year ago

Filed a patent for "process for producing dna formulations with lipopolymer delivery systems" on Tue, January 31, 2023

New US Patent
imnn
2 years ago

Filed a patent for "il-12 gene therapy and anti-vegf combination for treating cancer" on Wed, September 7, 2022

New US Patent
imnn
2 years ago

Filed a patent for "il-12 gene therapy for treating in brca-negative/homologous repair proficient cancers" on Tue, September 13, 2022

New US Patent
imnn
2 years ago

Filed a patent for "il-12 gene therapy and immune checkpoint inhibitor combination for treating cancer" on Tue, September 13, 2022

New US Patent
imnn
2 years ago

Filed a patent for "polynucleotide vaccine formulations and methods of using the same" on Fri, September 23, 2022

New US Patent